Previous 10 | Next 10 |
home / stock / epwcf / epwcf news
MediSure Laboratory to offer clinical study services for client expansion to US market VANCOUVER, BC / ACCESSWIRE / January 10, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) (" Empower " or the " Company ") an integrated healthcare company - serving patients through medical centers, a me...
Empower Clinics ( OTC:EPWCF ) said its unit Medisure Laboratory signed a clinical laboratory services agreement with Specialist Network of North America (SSNA). The agreement follows a partnership announced on Dec. 7, 2022 between Empower and SNNA to launch a healthcare network whose ...
MediSure Laboratory will provide clinical laboratory services to Specialist Network of North America as part of recently announced partnership VANCOUVER, BC / ACCESSWIRE / January 3, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) (" Empower " or the " Company ") an integrated healthcare c...
VANCOUVER, BC / ACCESSWIRE / December 23, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) (" Empower " or the " Company ") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory is pleased to...
Partnership with Atlas to focus on U.S. market with immediate sales and marketing of U.S. Government approved products and laboratory collaboration to secure further FDA approvals VANCOUVER, BC / ACCESSWIRE / December 19, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) (" Empower " or the ...
VANCOUVER BC / ACCESSWIRE / December 14, 2022 / EMPOWER CLINICS INC. ( CSE:EPW)(OTCQB:EPWCF) (" Empower " or the " Company ") today announces that on December 13, 2022, it completed a non-brokered private placement of units (each a " Unit ") at a price of $0.05 per Unit, for aggregate gross pro...
Partnership has mission to bring access to quality and affordable specialty healthcare to disadvantaged patients VANCOUVER, BC / ACCESSWIRE / December 7, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) (" Empower " or the " Company ") an integrated healthcare company - serving patients thr...
288% year over year increase in revenue in Q3 2022 VANCOUVER, BC / ACCESSWIRE / November 28, 2022 / EMPOWER CLINICS INC (CSE:EPW)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms,...
Eric Christian brings twenty years of experience in healthcare industry including scaling diagnostics laboratory VANCOUVER, BC / ACCESSWIRE / November 24, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) (" Empower " or the " Company ") an integrated healthcare company - serving patien...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / November 22, 2022 / EMPOWER CLINICS INC. ( CSE:EPW)(OTCQB:EPWCF) (" Empower " or the " Company ") today announces its intention to complete a non-brokered priv...
News, Short Squeeze, Breakout and More Instantly...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...